| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/17/2011 | US20110065799 Urokinase inhibitors, production and use thereof |
| 03/17/2011 | US20110065788 Aqueous formulations of (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate |
| 03/17/2011 | US20110065773 Rna interference mediating small rna molecules |
| 03/17/2011 | US20110065770 Formulations comprising antisense nucleotides to connexins |
| 03/17/2011 | US20110065763 Compositions for Topical Application Having Androgenic Actions |
| 03/17/2011 | US20110065746 Composition of solifenacin or salt thereof for use in solid formulation |
| 03/17/2011 | US20110065719 Pharmaceutical formulations containing flavouring substances with improved pharmaceutical |
| 03/17/2011 | US20110065718 Antifungal Product, Use and Formulation Thereof |
| 03/17/2011 | US20110065677 Methods of Treating Inflammation with Compositions Comprising Lecithin Oils and NSAIDS for Protecting the Gastrointestinal Tract and Providing Enhanced Therapeutic Activity |
| 03/17/2011 | US20110065587 Epitope testing using soluble hla |
| 03/17/2011 | US20110065109 Rna interference mediating small rna molecules |
| 03/17/2011 | US20110064821 Encapsulation of biologically active agents |
| 03/17/2011 | US20110064820 Pharmaceutical Compositions Comprising Phosphate-Binding Polymer |
| 03/17/2011 | US20110064819 Encapsulation of biologically active agents |
| 03/17/2011 | US20110064818 Pharmaceutical composition and a method for the production thereof |
| 03/17/2011 | US20110064817 Continuous multi-microencapsulation process for improving the stability and storage life of biologically active ingredients |
| 03/17/2011 | US20110064816 Atorvastatin compositions |
| 03/17/2011 | US20110064815 Silicia for the inhinition of a protease |
| 03/17/2011 | US20110064814 Stable pharmaceutical products |
| 03/17/2011 | US20110064813 Use of salsalate with or without caffeine and with or without omega 3, and other pharmaceutical compounds in a distinctively unique nano-particulate capsule and tablet |
| 03/17/2011 | US20110064812 Oral Solid Dosage Form Containing Nanoparticles and Process of Formulating the Same Using Fish Gelatin |
| 03/17/2011 | US20110064811 Solid forms of N-[2,4-BIS(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 03/17/2011 | US20110064810 Tissue engineering method for organ reconstruction using injectable matrix |
| 03/17/2011 | US20110064809 Scaffolds |
| 03/17/2011 | US20110064808 Extended release formulation of levetiracetam |
| 03/17/2011 | US20110064807 Extended release formulation of levetiracetam |
| 03/17/2011 | US20110064806 Solid compositions comprising an oxadiazoanthracene compound and methods of making and using the same |
| 03/17/2011 | US20110064805 Porous cellulose aggregate and molding composition thereof |
| 03/17/2011 | US20110064804 Methods and Compositions for the Treatment of CNS-Related Conditions |
| 03/17/2011 | US20110064803 Nanoparticulate and controlled release compositions comprising vitamin k2 |
| 03/17/2011 | US20110064802 Improved capsule with air-vents |
| 03/17/2011 | US20110064801 Pharmaceutical Formulations Containing an SGLT2 Inhibitor |
| 03/17/2011 | US20110064800 Nanoparticulate and controlled release compositions comprising cyclosporine |
| 03/17/2011 | US20110064799 Pancreatic Enzyme Compositions and Methods for Treating Pancreatitis and Pancreatic Insufficiency |
| 03/17/2011 | US20110064798 Suspension containing hydronium stabilized colloidal silicic acid nanoparticles, formulation obtained from the said dilutesuspension, powder obtained from the said de-hydrated suspension, compositions obtained from the said powder, preparation and use |
| 03/17/2011 | US20110064797 Capsule of thermogenic cells for treating a metabolic disease |
| 03/17/2011 | US20110064796 Concentrated, inhalable antibiotic formulation |
| 03/17/2011 | US20110064795 Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers |
| 03/17/2011 | US20110064794 Drug Delivery System, its Preparation Process and Use |
| 03/17/2011 | US20110064793 Inhibitors of hiv replication and method of treatment of hiv infections |
| 03/17/2011 | US20110064792 Method for Opening Tight Junctions |
| 03/17/2011 | US20110064791 Self forming, thermodynamically stable liposomes and their applications |
| 03/17/2011 | US20110064790 Adaptable modified virus vector to deliver ribosomal ribonucleic acid as a medical treatment device to manage diabetes mellitus and other protein deficient diseases |
| 03/17/2011 | US20110064789 Docosahexanoic acid as inhibitor of h. pylori |
| 03/17/2011 | US20110064788 Pharmaceutical compositions for treatment of addiction |
| 03/17/2011 | US20110064787 Detoxifying patch |
| 03/17/2011 | US20110064786 Novel use of basic fibroblast growth factor in the de-differentiation of animal connective tissue cells |
| 03/17/2011 | US20110064785 Nanostructure-Enhanced Platelet Binding and Hemostatic Structures |
| 03/17/2011 | US20110064784 Method for producing a three-dimensional macroporous filament construct based on phase inversion and construct thereby obtained |
| 03/17/2011 | US20110064783 Flavor Impregnation Of A Chewing Gum Core |
| 03/17/2011 | US20110064782 Methods and compositions for tissue regeneration |
| 03/17/2011 | US20110064780 Polymeric pheromone formulation and method of use to calm stress-related behavior in mammals over an extended period of time |
| 03/17/2011 | US20110064776 Dental composition containing organic nanotube |
| 03/17/2011 | US20110064775 Metallo-organic system for the encapsulation and release of compounds of interest, method for obtaining same and uses thereof |
| 03/17/2011 | US20110064774 Bulking agent |
| 03/17/2011 | US20110064773 pharmaceutical compositions comprising a thyroid hormon and their therapeutic use |
| 03/17/2011 | US20110064677 Lipoxin analogs and methods for the treatment of periodontal disease |
| 03/17/2011 | US20110064676 Diagnostic and therapeutic nanoparticles |
| 03/17/2011 | US20110064675 Elemental iron nanoparticles |
| 03/17/2011 | US20110064665 Diagnostic and therapeutic nanoparticles |
| 03/17/2011 | US20110061651 Formoterol superfine formulation |
| 03/17/2011 | US20110061345 Solid and semi-solid dosage forms and systems and methods for forming and packaging thereof |
| 03/17/2011 | DE19626431B4 Verwendung einer pharmazeutische Komposition mit antialkoholischer und nootroper Wirkung Use of a pharmaceutical composition with anti alcoholic and nootropic effect |
| 03/17/2011 | CA2773737A1 Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same |
| 03/17/2011 | CA2773628A1 Solid dispersion comprising an anti-hiv agent |
| 03/17/2011 | CA2773588A1 Choline fenofibrate delayed release compositions |
| 03/17/2011 | CA2773491A1 Implantable device for controlled drug delivery |
| 03/17/2011 | CA2773249A1 Oral suspension formulations of esclicarbazepine acetate |
| 03/17/2011 | CA2773008A1 Transdermal therapeutic system for administering fentanyl or an analogue thereof |
| 03/17/2011 | CA2772750A1 Antacid and laxative tablet |
| 03/17/2011 | CA2772084A1 Implantable device for production of interleukin-1 receptor antagonist |
| 03/17/2011 | CA2772067A1 Methods and compositions for delivering interleukin-1 receptor antagonist |
| 03/17/2011 | CA2771571A1 Highly concentrated pharmaceutical formulations |
| 03/17/2011 | CA2770714A1 Methods and systems for dosing and coating inhalation powders onto carrier particles |
| 03/16/2011 | EP2295578A2 Cyp1b1 nucleic acids and methods of use |
| 03/16/2011 | EP2295067A1 E-selectin for inducing immunotolerance |
| 03/16/2011 | EP2295062A1 The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 03/16/2011 | EP2295058A1 Depot formulations of iloperidone with a polymer |
| 03/16/2011 | EP2295056A1 Use of SNS-595 for treating leukemia |
| 03/16/2011 | EP2295046A1 Transdermal therapeutic system for application of fentanyl or an analogue material thereof |
| 03/16/2011 | EP2295045A1 Nanoparticles for nucleic acid delivery |
| 03/16/2011 | EP2295044A1 Encapsulation using waxy substances |
| 03/16/2011 | EP2295043A1 Controlled release hydrocodone formulations |
| 03/16/2011 | EP2295042A1 Controlled release hydrocodone formulations |
| 03/16/2011 | EP2295041A2 HRT formulations |
| 03/16/2011 | EP2295040A1 Pharmaceutical compositions of pramipexole |
| 03/16/2011 | EP2295039A1 Pancreatin pellets, in particular pancreatin micropellets and method for producing same |
| 03/16/2011 | EP2295038A1 Solid dispersion comprising an anti-HIV agent |
| 03/16/2011 | EP2295037A1 Pharmaceutical formulation containing Ribavirin |
| 03/16/2011 | EP2295036A2 Liquid compositions and methods for treating conditions of the nail unit |
| 03/16/2011 | EP2295035A2 Dual-acting pharmaceutical compositions based on superstructures of angiotensin receptor antagonist/blocker (ARB) and neutral endopeptidase (NEP) inhibitor |
| 03/16/2011 | EP2293921A1 Membrane precursors and membranes formed therefrom |
| 03/16/2011 | EP2293867A2 Device and method for making solid beads |
| 03/16/2011 | EP2293817A1 Stabilized liquid formulation |
| 03/16/2011 | EP2293800A2 Compositions and methods for treatment of ear disorders |
| 03/16/2011 | EP2293794A1 Methods of treating mammals with eustachian tube dysfunctions |
| 03/16/2011 | EP2293791A1 Pharmaceutical compositions of entacapone co-micronized with sugar alcohols |
| 03/16/2011 | EP2293787A1 Nanoemulsions for treating fungal, yeast and mold infections |
| 03/16/2011 | EP2293786A2 Tablettable chewing gums comprising nicotine and a buffering agent |
| 03/16/2011 | EP2293785A2 Nanoparticles containing a peptide, vectors containing the same and pharmaceutical uses of said nanoparticles and said vectors |